WRBY Warby Parker Inc. Insider Trading

WRBY then-CEO Gilboa sold 54,347 shares at $29.84 ($1.6M) via 10b5-1 plan, retaining 31,112 direct shares plus 9,704,346 derivative shares.

David Abraham Gilboa, who was Co-Chief Executive Officer at the time, sold 54,347 shares of Warby Parker Inc. (WRBY) at $29.84 on 2026-07-06 for total proceeds of $1,621,714.48, under a 10b5-1 trading plan adopted on 2026-03-17 — making this a scheduled, non-discretionary transaction. His non-derivative holdings fell from 85,459 shares to 31,112 shares (-63.6%), but his overall position remains substantial through 9,704,346 shares in derivative vehicles including 539,191 stock options and Class B Common Stock positions of 4,609,751 and 4,555,404 shares. His cross-ticker track record across 20 prior open-market sells shows an avg 30-day return of -8.4% and avg 90-day return of -13.6%, and his 5 prior WRBY-specific sells have all shown negative 90-day returns, ranging from -9.7% to -28.0%. The stock has risen +32.1% over the prior 90 days and trades at a P/E of 2767.00 against a market cap of $3,131,772,918.25, with the current price of $27.67 sitting -10.7% below the 52-week high of $31.00.

Co-CEO Neil Harris Blumenthal sold 217,667 shares of WRBY at $29.61 on 2026-07-01 under pre-arranged 10b5-1 plan; retains 31,112 shares plus derivative holdings.

Neil Harris Blumenthal executed a scheduled sale of 217,667 shares for $6,445,119.87 under a pre-arranged 10b5-1 trading plan adopted on 2026-03-17, reducing his non-derivative holdings by 87.5% to 31,112 shares while retaining 3,229,650 shares in Class B Common Stock. The sale price of $29.61 is -5.6% from the 52-week high of $31.00, occurring after a 30-day +16.6% rally and 90-day +44.2% gain in the stock. Across his cross-ticker track record, his prior 20 open-market sells averaged -3.3% returns over 30 days and -17.2% over 90 days; at WRBY specifically, his five prior sales showed mixed near-term outcomes ranging from -13.6% to +19.3% over 30 days. Given the 10b5-1 structure, this transaction is scheduled rather than discretionary, and the insider retains substantial derivative holdings alongside the reduced non-derivative position.

Co-CEO David Gilboa sells 242,221 WRBY shares for $7.2M under 10b5-1 plan; holds 31,112 non-derivative shares post-sale

David Abraham Gilboa, who was Co-Chief Executive Officer at the time of filing, executed a scheduled sale of 242,221 shares at $29.69 on 2026-07-01 under a pre-arranged 10b5-1 trading plan adopted on 2026-03-17. This transaction reduced his non-derivative holdings by -88.6% vs pre-transaction holdings, though he retains 9,918,092 total derivative securities across three ownership vehicles. The stock has appreciated +16.6% over the 30-day period and +44.2% over the 90-day period following the sale, while his prior trades at this ticker show mixed patterns: five recent WRBY sales posted 30-day returns ranging from -27.5% to +13.6% and 90-day returns ranging from -28.0% to -2.0%. The company trades at a P/E of 2926.00 on net income of $3,177,000.00, reflecting extremely tight profitability margins relative to market valuation; the recent quarter posted revenue of $242,447,000.00 against annual revenue growth of +13.0%.

WRBY co-CEO Blumenthal sells 36.3K shares at $30.04 under scheduled 10b5-1 plan; retains 59.5K non-derivative shares

Neil Harris Blumenthal, Co-Chief Executive Officer, sold 36,300 shares of WRBY at $30.04 on 2026-06-29 for $1,090,452.00 as part of a pre-arranged 10b5-1 trading plan adopted on 2025-09-16—a scheduled transaction, not a discretionary action. His post-transaction non-derivative holdings stand at 59,459 shares, down 37.9% from the 95,759 shares held before this sale. The stock currently trades at $29.37, down 5.3% from its 52-week high of $31.00, though it is up 20.5% over the past 30 days and +44.8% over 90 days. Across his cross-ticker track record, his prior 20 open-market sells averaged -3.3% 30-day returns and -17.2% 90-day returns; his same-ticker history at WRBY shows mixed recent outcomes, with one May 2026 sale down 13.6% at 30 days and earlier April sales posting gains of 14.7%, 18.3%, and 19.3% at 30 days.

Neil Harris Blumenthal (Co-CEO) sold 63,040 shares of WRBY at $30.03 under pre-arranged 10b5-1 plan; stock now $24.50.

Neil Harris Blumenthal sold 63,040 shares (-55.7% vs pre-transaction holdings) on 2026-05-19 at $30.03 under a pre-arranged 10b5-1 trading plan adopted on 2025-09-16, making this a scheduled transaction rather than a discretionary choice. The current price of $24.50 is -21.0% from the 52-week high of $31.00, and the stock is down 2.6% over 30 days. Across his cross-ticker track record, his prior 20 sells averaged -2.7% return over 30 days and -14.5% over 90 days, while at WRBY specifically his 5 prior trades showed mixed near-term performance ranging from -5.8% to +19.3% at 30 days. The company reports $242.4M revenue in the latest quarter with +13.0% annual growth, but carries a P/E of 2450.00 on net income of $3.2M, signaling thin profitability relative to valuation.

WRBY Co-CEO Blumenthal sells 100,000 shares for $2.5M via scheduled 10b5-1 plan (Apr 16-20)

Co-Chief Executive Officer Neil Harris Blumenthal executed 4 separate sales totaling 100,000 shares for $2,467,129.65 between April 16 and April 20, 2026, at prices ranging from $24.08 to $25.09 per share, consistent with a pre-arranged 10b5-1 trading plan adopted on September 16, 2025. This represents a -66.6% reduction in his shareholdings, from 150,165 to 50,165 shares post-transaction. Since the sales were executed pursuant to a scheduled 10b5-1 plan rather than a discretionary decision, they do not convey timing or conviction-based signals. The sale is material in absolute terms given the 100.0K shares and $2.5M aggregate value, but investors should note that a substantial derivative position in Table II—not yet populated in the database—may represent additional economic interest and should be reviewed to assess the insider's full stake.

Co-CEO David Abraham sold 80,094 shares of WRBY at $29.46 on 2026-01-13, reducing stake by 68.3% to 37,247 shares.

Gilboa David Abraham, Co-Chief Executive Officer, sold 80,094 shares at $29.46 on 2026-01-13, reducing his holdings from 117,341 shares to 37,247 shares—a 68.3% reduction in stake. The sale occurred near the 52-week high ($30.23), with the stock currently trading at $28.33, -6.3% from its peak. This represents a substantial decrease in Abraham's direct equity position despite the company's +15.2% annual revenue growth, though the company remains unprofitable on a full-year basis with a P/E of 2833.00. However, a derivative-conversion flag indicates this may reflect a conversion or reallocation of derivative securities rather than a pure exit from economic exposure. Notably, Abraham has executed five separate sales at WRBY in rapid succession (2025-12-11 through 2026-01-13), though none yet have measurable 90-day outcomes to assess timing accuracy.

Co-CEO Gilboa sold 94,906 shares at $27.51 avg (2 sales, $2.6M); retains 37,247 shares post-derivative conversion.

David Abraham, Co-Chief Executive Officer at Warby Parker, executed 2 separate sales totaling 94,906 shares for $2,610,815.54 between January 7–9, 2026 (blended average $27.51 per share). Following a derivative conversion, he retains 37,247 shares. The stock has declined 4.3% over the past 30 days and 6.4% from its 52-week high of $30.23, trading near that peak. Across his cross-ticker track record, Abraham's 20 prior sells have been well-timed at the 90-day mark 88.24% of the time, with an average 90-day return of -12.4%; his 2 prior measurable sales at WRBY specifically were also well-timed at the 90-day horizon. However, 3 of his 5 recent WRBY sales (2025-12-11, 2026-01-02, 2026-01-06) remain unmeasurable. The company's fundamentals show elevated valuation (P/E 2830) despite strong quarterly revenue of $221.7M and 15.2% annual growth, though the business remains unprofitable on a full-year basis. The pattern of near-calendar sales and strong historical timing merit monitoring as earnings unfold.

Co-CEO Blumenthal sold 50,000 WRBY shares at $27.08 on 2026-01-07; post-sale holdings 37,119 shares (-57.4% reduction).

Blumenthal sold 50,000 shares of Warby Parker at $27.08, reducing his holdings by 57.4% from 87,119 to 37,119 shares in a single transaction worth $1,354,000.00. This follows a pattern of four recent sells at the same ticker on 2026-01-06 and 2025-12-11, with only one prior measurable outcome at WRBY (a 2025-09-11 sale that showed +7.4% 90-day return, indicating the stock rose after sale). At the broader cross-ticker level, the insider's 20 prior sells averaged +0.8% over 90 days with a 68.75% well-timed rate, suggesting his sales have historically preceded modest gains rather than declines. The company's current valuation (P/E of 2830.00) reflects very limited profitability; Q4 revenue of $221.7M yielded only $5.9M net income, and the full fiscal year was unprofitable. The stock is trading 6.4% below its 52-week high and down 4.3% over 30 days despite a 27.1% 90-day gain.

WRBY co-CEO Gilboa David Abraham sells 75,000 shares across 2 transactions for $1,776,000 via 10b5-1 plan

Gilboa David Abraham, who was Co-Chief Executive Officer at the time of filing, executed 2 separate sales totaling 75,000 shares for $1,776,000 (blended average price $23.68) on 2026-01-02 and 2026-01-06. This sale reduced his holdings from 112,247 shares to 37,247 shares, a decrease of 75,000 shares (-66.8% vs pre-transaction holdings). The transaction was part of a pre-arranged 10b5-1 trading plan adopted on 2025-09-16, meaning it was scheduled rather than discretionary. IMPORTANT: The filing contains a derivative-conversion notation in Table II (not yet populated in our database), indicating the insider's real position extends beyond the Table I share count shown here—investors should review the full Form 4 Table II to understand the complete position including derivative holdings and their conversion status.